Current perspectives on the immunopathogenesis of systemic sclerosis
- PMID: 27529059
- PMCID: PMC4970639
- DOI: 10.2147/ITT.S82037
Current perspectives on the immunopathogenesis of systemic sclerosis
Abstract
Systemic sclerosis (SSc or scleroderma) is a progressive and highly debilitating autoimmune disorder characterized by inflammation, vasculopathy, and extensive fibrosis. SSc is highly heterogeneous in its clinical presentation, extent and severity of skin and internal organ involvement, and clinical course and has the highest fatality rate among connective tissue diseases. While clinical outcomes have improved in recent years, no current therapy is able to reverse or slow the natural progression of SSc, a reflection of its complex pathogenesis. Although activation of the immune system has long been recognized, the mechanisms responsible for the initiation of autoimmunity and the role of immune effector pathways in the pathogenesis of SSc remain incompletely understood. This review summarizes recent progress in disease pathogenesis with particular focus on the immunopathogenetic mechanisms of SSc.
Keywords: autoimmunity; immune mediators; inflammation; scleroderma.
Figures

Similar articles
-
Early inflammatory players in cutanous fibrosis.J Dermatol Sci. 2017 Sep;87(3):228-235. doi: 10.1016/j.jdermsci.2017.06.009. Epub 2017 Jun 15. J Dermatol Sci. 2017. PMID: 28655471 Review.
-
Systemic sclerosis: Is the epithelium a missing piece of the pathogenic puzzle?J Dermatol Sci. 2019 May;94(2):259-265. doi: 10.1016/j.jdermsci.2019.04.007. Epub 2019 May 1. J Dermatol Sci. 2019. PMID: 31079997 Review.
-
Role of microRNA in the pathogenesis of systemic sclerosis tissue fibrosis and vasculopathy.Autoimmun Rev. 2019 Nov;18(11):102396. doi: 10.1016/j.autrev.2019.102396. Epub 2019 Sep 11. Autoimmun Rev. 2019. PMID: 31520794 Review.
-
The role of platelets in autoimmunity, vasculopathy, and fibrosis: Implications for systemic sclerosis.Semin Arthritis Rheum. 2017 Dec;47(3):409-417. doi: 10.1016/j.semarthrit.2017.05.004. Epub 2017 May 23. Semin Arthritis Rheum. 2017. PMID: 28602360 Review.
-
Pathogenesis of systemic sclerosis: an integrative review of recent advances.J Rheum Dis. 2025 Apr 1;32(2):89-104. doi: 10.4078/jrd.2024.0129. Epub 2024 Nov 28. J Rheum Dis. 2025. PMID: 40134549 Free PMC article. Review.
Cited by
-
Echinochrome A Treatment Alleviates Fibrosis and Inflammation in Bleomycin-Induced Scleroderma.Mar Drugs. 2021 Apr 23;19(5):237. doi: 10.3390/md19050237. Mar Drugs. 2021. PMID: 33922418 Free PMC article.
-
Analysis of gene expression profiles and protein-protein interaction networks in multiple tissues of systemic sclerosis.BMC Med Genomics. 2019 Dec 27;12(1):199. doi: 10.1186/s12920-019-0632-2. BMC Med Genomics. 2019. PMID: 31881890 Free PMC article.
-
Gastrointestinal Manifestations of Systemic Sclerosis.Rheumatology (Sunnyvale). 2018;8(1):235. doi: 10.4172/2161-1149.1000235. Epub 2018 Mar 30. Rheumatology (Sunnyvale). 2018. PMID: 30057856 Free PMC article.
-
Fibronectin-EDA accumulates via reduced ubiquitination downstream of Toll-like receptor 9 activation in SSc-ILD fibroblasts.Am J Physiol Lung Cell Mol Physiol. 2022 Oct 1;323(4):L484-L494. doi: 10.1152/ajplung.00019.2022. Epub 2022 Aug 23. Am J Physiol Lung Cell Mol Physiol. 2022. PMID: 35997276 Free PMC article.
-
Effect of purine-rich box1 on proliferation of fibroblasts.Int J Ophthalmol. 2020 Nov 18;13(11):1827-1832. doi: 10.18240/ijo.2020.11.22. eCollection 2020. Int J Ophthalmol. 2020. PMID: 33215017 Free PMC article. Review.
References
-
- Gabrielli A, Avvedimento EV, Krieg T. Scleroderma. N Engl J Med. 2009;360(19):1989–2003. - PubMed
-
- Barnes J, Mayes MD. Epidemiology of systemic sclerosis: incidence, prevalence, survival, risk factors, malignancy, and environmental triggers. Curr Opin Rheumatol. 2012;24(2):165–170. - PubMed
-
- Medsger TA., Jr Natural history of systemic sclerosis and the assessment of disease activity, severity, functional status, and psychologic well-being. Rheum Dis Clin North Am. 2003;29(2):255–273. vi. - PubMed
-
- Medsger TA., Jr . Classification, prognosis. In: Clements PJ, Furst DE, editors. Systemic Sclerosis. 2nd ed. Philadelphia: Lippincott Williams and Williams; 2004. pp. 17–28.
-
- Mayes MD. Scleroderma epidemiology. Rheum Dis Clin North Am. 2003;29(2):239–254. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
Molecular Biology Databases